Cognitive Function in IPF
Research type
Research Study
Full title
Investigation into the relationship between stable normoxic Idiopathic Pulmonary Fibrosis and cognitive dysfunction
IRAS ID
167905
Contact name
Charles Sharp
Contact email
Sponsor organisation
North Bristol NHS Trust
Duration of Study in the UK
0 years, 12 months, 0 days
Research summary
Idiopathic pulmonary fibrosis (IPF) is a chronic progressive disease with only one currently approved disease modifying treatment, however there have been recent advances in our understanding which have led to clinical trials examining the safety and efficacy of several promising drugs. It is therefore important to identify and characterise clinically important outcomes for these novel treatments. IPF has been associated with several co-morbidities, including coronary artery disease and venous thromboembolic disease. Cognitive dysfunction is one such clinically important co-morbidity, known to be associated with impaired lung function but has yet to be examined in IPF. This study aims to establish any association between stable normoxaemic patients with IPF and cognitive dysfunction, which may suggest a multi-system disease process, or indicate important disease-related consequences.
REC name
East Midlands - Derby Research Ethics Committee
REC reference
14/EM/1292
Date of REC Opinion
17 Dec 2014
REC opinion
Further Information Favourable Opinion